Cite
HARVARD Citation
Shrewsbury, S. et al. (2019). STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD®) Device, in Healthy Adult Subjects. Headache. 59 (3), pp. 394-409. [Online].